Leveraging deep learning algorithms for synthetic data generation to design and analyze biological networks.

The use of synthetic data is gaining an increasingly prominent role in data and machine learning workflows to build better models and conduct analyses with greater statistical inference. In the domains of healthcare and biomedical research, synthetic data may be seen in structured and unstructured formats. Concomitant with the adoption of synthetic data, a sub-discipline of machine learning known as deep learning has taken the world by storm. At a larger scale, deep learning methods tend to outperform traditional methods in regression and classification tasks. These techniques are also used in generative modeling and are thus prime candidates for generating synthetic data in both structured and unstructured formats. Here, we emphasize the generation of synthetic data in healthcare and biomedical research using deep learning methods for unstructured data formats such as text and images. Deep learning methods leverage the neural network algorithm, and in the context of generative modeling, several neural network architectures can create new synthetic data for a problem at hand including, but not limited to, recurrent neural networks (RNNs), variational autoencoders (VAEs), and generative adversarial networks (GANs). To better understand these methods, we will look at specific case studies such as generating realistic clinical notes of a patient, the generation of synthetic DNA sequences, as well as to enrich experimental data collected during the study of heterotypic cultures of cancer cells.

Dynamic Phenotypic Switching and Group Behavior Help Non-Small Cell Lung Cancer Cells Evade Chemotherapy.

Drug resistance, a major challenge in cancer therapy, is typically attributed to mutations and genetic heterogeneity. Emerging evidence suggests that dynamic cellular interactions and group behavior also contribute to drug resistance. However, the underlying mechanisms remain poorly understood. Here, we present a new mathematical approach with game theoretical underpinnings that we developed to model real-time growth data of non-small cell lung cancer (NSCLC) cells and discern patterns in response to treatment with cisplatin. We show that the cisplatin-sensitive and cisplatin-tolerant NSCLC cells, when co-cultured in the absence or presence of the drug, display dynamic group behavior strategies. Tolerant cells exhibit a 'persister-like' behavior and are attenuated by sensitive cells; they also appear to 'educate' sensitive cells to evade chemotherapy. Further, tolerant cells can switch phenotypes to become sensitive, especially at low cisplatin concentrations. Finally, switching treatment from continuous to an intermittent regimen can attenuate the emergence of tolerant cells, suggesting that intermittent chemotherapy may improve outcomes in lung cancer.